Exercise‐induced inhibition of angiotensin II vasoconstriction in human thigh muscle
Authors:
Open Access
- 24 November 2006
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 577 (2) , 727-737
Abstract
It is well established that metabolic inhibition of adrenergic vasoconstriction contributes to the maintenance of adequate perfusion to exercising skeletal muscle. However, little is known regarding nonadrenergic vasoconstriction during exercise. We tested the hypothesis that a non‐adrenergic vasoconstrictor, angiotensin II (AngII), would be less sensitive to metabolic inhibition than an α1‐agonist, phenylephrine (PE), in the exercising human thigh. In 11 healthy men, femoral blood flow (FBF, ultrasound Doppler and thermodilution) and blood pressure were evaluated during wide‐ranging doses of intra‐arterial (femoral) infusions of PE and AngII at rest and during two workloads of steady‐state knee‐extensor exercise (7 W and 27 W). At rest, the maximal decrease in femoral artery diameter (FAD) during AngII (9.0 ± 0.2 to 8.4 ± 0.4 mm) was markedly less than during PE (9.0 ± 0.3 to 5.7 ± 0.5 mm), whereas maximal reductions in FBF and femoral vascular conductance (FVC) were similar during AngII (FBF: −65 ± 6 and FVC: −66 ± 6%) and PE (−57 ± 5 and −59 ± 4%). During exercise, FAD was not changed by AngII, but moderately decreased by PE. The maximal reductions in FBF and FVC were blunted during exercise compared to rest for both AngII (7 W: −28 ± 5 and −40 ± 5%; 27 W: −15 ± 4% and −29 ± 5%) and PE (7 W: −30 ± 4 and −37 ± 6%; 27 W: −15 ± 2 and −24 ± 6%), with no significant differences between drugs. The major new findings are (1) an exercise‐induced intensity‐dependent metabolic attenuation of non‐adrenergic vasoconstriction in the human leg; and (2) functional evidence that AngII‐vasoconstriction is predominantly distal, whereas α1‐vasoconstriction is proximal and distal within the muscle vascular bed of the human thigh.Keywords
This publication has 60 references indexed in Scilit:
- Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failureAmerican Heart Journal, 2005
- Vascular Response to Angiotensin II in Upper Body ObesityHypertension, 2004
- Sympathetic Augmentation in HypertensionHypertension, 2004
- Crosstalk between presynaptic angiotensin receptors, bradykinin receptors and α2‐autoreceptors in sympathetic neurons: a study in α2‐adrenoceptor‐deficient miceBritish Journal of Pharmacology, 2003
- Superiority of endothelin-1 over norepinephrine in exercise-induced alterations of the conduit artery tone of the non-exercised arm in patients with chronic heart failureInternational Journal of Cardiology, 2000
- Functional Importance of Angiotensin-Converting Enzyme–Dependent In Situ Angiotensin II Generation in the Human ForearmHypertension, 2000
- Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissuesBritish Journal of Pharmacology, 1999
- Regulation of regional norepinephrine spillover in heart failure: The effect of angiotensin ii and β-adrenergic agonists in the forearm circulationJournal of Cardiac Failure, 1998
- Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.Journal of Clinical Investigation, 1994